Compare OC & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OC | DVA |
|---|---|---|
| Founded | 1938 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Misc Health and Biotechnology Services |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5B | 9.9B |
| IPO Year | 2006 | 2002 |
| Metric | OC | DVA |
|---|---|---|
| Price | $108.33 | $195.16 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 4 |
| Target Price | $145.27 | ★ $156.75 |
| AVG Volume (30 Days) | ★ 1.0M | 850.5K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.61% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 2.87 |
| Revenue | N/A | ★ $13,643,069,000.00 |
| Revenue This Year | N/A | $3.85 |
| Revenue Next Year | $3.72 | $3.07 |
| P/E Ratio | ★ N/A | $69.91 |
| Revenue Growth | N/A | ★ 6.46 |
| 52 Week Low | $97.53 | $101.00 |
| 52 Week High | $159.42 | $202.69 |
| Indicator | OC | DVA |
|---|---|---|
| Relative Strength Index (RSI) | 34.35 | 69.63 |
| Support Level | $103.31 | $145.58 |
| Resistance Level | $110.63 | $202.69 |
| Average True Range (ATR) | 4.58 | 7.59 |
| MACD | -1.72 | 1.92 |
| Stochastic Oscillator | 7.86 | 86.34 |
Owens-Corning Inc is a building products company that offers roofing products and systems, insulation products (hermal and acoustical batts, loose fill insulation, spray foam insulation, wet use chopped strand, etc.), and doors and door systems. The company's reportable segments are: Roofing, Insulation, and Doors. Maximum revenue is generated from the Roofing segment, which manufactures and sells residential roofing shingles, oxidized asphalt materials, roofing components, and composite lumber mainly used in residential construction. This segment also manufactures and sells glass mat and specialty veil materials used in building and construction applications. Geographically, the company generates maximum revenue from the United States, followed by Europe, Asia-Pacific, and other markets.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.